Revill, Peter
Testoni, Barbara
Locarnini, Stephen
Zoulim, Fabien
Article History
First Online: 24 February 2016
Change Date: 17 March 2016
Change Type: Correction
Change Details: In the version of this article originally published online, the affiliation address for Peter Revill and Stephen Locarnini was incorrect and should have read: Victorian Infectious Disease Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Victoria, 3010, Australia. This error has now been corrected for the print, HTML and PDF versions of the article.
Competing interests
: P.R. received research funding from Gilead Sciences. B.T. declares no competing interests. S.L. received research funding from Arrowhead and Gilead Sciences and consultancies from Arrowhead, Gilead Sciences and Janssen. F.Z. received research grants from Assembly Bioscience, Gilead Sciences, Janssen, Novira and Roche, and consultancies from Bristol Myers Squibb, Gilead Sciences, Janssen, Medimmune, Novira, Roche and Tekmira.